lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: sun pharmaceutical industries, inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
sun pharmaceutical industries, inc.
Dosage Form
TABLET, CHEWABLE
Routes
Active Ingredients
lisdexamfetamine dimesylate 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
57664-085
Product ID
57664-085_0b77417a-5789-8818-e063-6294a90ad2e3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214134
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2023-08-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57664085
Hyphenated Format
57664-085
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA214134 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 100 TABLET, CHEWABLE in 1 BOTTLE (57664-085-88)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0b77417a-5789-8818-e063-6294a90ad2e3", "openfda": {"unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856", "1871456", "1871460", "1871462", "1871464", "1871466", "1871468"], "spl_set_id": ["da3148af-f9b6-4725-adae-3595b4c7dc4b"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (57664-085-88)", "package_ndc": "57664-085-88", "marketing_start_date": "20230825"}], "brand_name": "LISDEXAMFETAMINE DIMESYLATE", "product_id": "57664-085_0b77417a-5789-8818-e063-6294a90ad2e3", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "57664-085", "dea_schedule": "CII", "generic_name": "LISDEXAMFETAMINE DIMESYLATE", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISDEXAMFETAMINE DIMESYLATE", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "ANDA214134", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}